Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
2 wrongs don't make a right, that is also bad investing. The clear message is smart money has avoided the stock since really starting with asco in 2010, 8 years. $50 million rights has to mean a new message if it succeeds, but the delayed rights deal has cheapened further this story every way one can evaluate
I believe she stated enough money to last through August, nope the issue is whether the company can get pick itself up, we shall see, but $1.75 is not cheap anymore regardless
Everybody that voted No violated fiduciary responsibility as part owner, a fact that will never be accepted
A better topic choice would be the need for $2 million per month which turned smart money away, I accept the $2 million looks like a hard fact akin to gravity whether truly necessary as a function or not
My slant is excessively poor fund raising ability, but if the offering makes big bucks that will be like THE THREE STOOGES beating the Patriots in the Super Bowl. And then what if case may be?
To keep it simple for all of us, as bad as the mind blowing convertible was, so far money raising since then has oscillated between poor and so poor, it begs the question does it matter whether any fraudulent intent from management exists or not
There would be massive head scratching if smart money ($50 million) buy on rights, even lesser substantial amounts. Another point starting with June of last year, stock price movement often is a disconnect with being informative.
Looks crooked enough to suit me sadly, I am not excercising any rights, based on my current impression
They never specifically stated a day, but apparently the company underspent by $4 million or maybe more based on comparing cash utilized vs. operating loss as well as accounts payable growth. Plus down maybe $6 million on these loans. It is pretty foggy on exactly how bad the balance sheet is as I don't have the expertise. My rights execution is going to be modest. Perfection of $50 million is not required, but getting in that ballpark is needed to smooth the gaping, jagged edges
The only person I noticed pointing out the ugly is you. I never paid attention to things like accounts payable before, but it sure seems like the company is hanging by a fingernail from a cliff
The only Queen is Queen Simpson. A very honest 10Q but your persistent hammering on how ugly it is, that is my concern, slicing my rights to maybe 2000 shares. $27 million I call a win, but adjusting need $30 m plus to be bullish
I doubt it is important as Polyanna Sam hopes that recent insider buying is a leading indicator of good. In one way $27 million is so huge compared to current market cap, but the financial suffering of this company needs a turn a round for which even $27 million is a lightweight
We can warily circle the barn trying to attack positions on financial status, but I am sticking with $27 million gross as the mark for a win, that would not include any backstop additional.
Price would be unpredictable after, but a much larger market cap and absolute proof of serious money is in it to win.
Too early to say about future purchases other than after rights bringing my total shares to 3394, I am going to delay possibly until Friday though to see how the stock trades
Maybe after an offering if debt paid down, we can agree on next quarterly statement, but that is tight time frame given end of Sep may not clear the air. In the meantime the quarterly imo has mildly positive numbers, so I turn my attention to offering, if I have the time tomorrow I will start my rights process for 3000 shares
lot of figures, operating cost for quarter was $6.1 million, however net cash for 6 months using in operating only $9.277
I don't think so, but I don't understand the $20 to $25 million needed as stated. Some of that could come in early 2019. Cash usage did not look that large.
Looks to me like last 10 Q was not audited as well. According to googling, 10 Qs are generally not audited.
5 percent chance future RS. 5 plus percent chance bankruptcy. If phase 3 works out, 90 percent change of $100 plus million marketcap
I don't know about negative results, near $700K is the norm, maybe I will drop 3000 to 2000 rights on $700K, If $600K or less glue myself to sidelines
Trompete has ratcheted up my worry. I am sick of delcath has not had an 800K quarter, it has been off my mind, but now it is on.
Interesting, lack of money seems like the obstacle to fear
Nothing wrong with suspicion, but last half of 2017 in particular has a spin to which there is more than one interpretation. Open mind to good and bad
Nothing has been really bad since the offering idea was first floated imo, so who knows. The phase 3 makeover is interesting
No idea about the postponement on 10Q. There is no proof but I think Simpson is a straight shooter on wanting $50 million. I like the idea a lot, actual amount raised could be from failure at zero to $50 million. I think extremely, extremely off base to not be impressed if 50
You are diverting from correct history. Latter half of 2017 people ignored July filing that shot down a buyout was coming, even first 3 months of 2018 the Simon Pedder story was running hard. I am not too concerned if I am currently wrong, won't be the first time this year I could lose money on delcath
My guess they will each buy 50K shares at $1.75 but the big guy interests me more, if he puts in $3 million, he is not doing it blind
Well it is an IF. But if $50 million was done, where will future beliefs head, not your beliefs but retail of the future
There is generally a mix of luck and skill. Smart money has known for years to stay away. Everybody should look closely at the resume of the man on bod since 2014. Not a man that would engage in head fakes, my opinion
The only reason I will probably jump into the rights is because I think near $4 million rights by insiders is probable.
If among other IF's insiders put $4 million in the offer, where do you think price will be in one month, 6 months, etc..?
$50 million gross allows the luxury of putting off 12 months until a likely round of financing. If full enrollment by end of June, speculation would surely be on the rise. I will be very disappointed if the focus on overall survival is negligible, regardless of timing. What market cap is delcath capable of if overall survival does not get touted? Maybe everybody but the shoddy FDA would weight OS heavily.
I consider it good news if complete enrollment announced. Great news would be additional good stuff said. So 2019 is a time for anticipation, market cap all during 2019 could be a guessing game, this offering is a major hill to the 2019 story. 2019 could be a major disappointment so I am open to the possibility of trading as needed through thick and thin
If the company manages to be swimming in money, after that if a drop below $1.75 is a golden buy opportunity, BECAUSE the company would not need money. The company is going to need still some money if $27 million gross but if $50 million gross, that is a land of need still far away
Success changes everything. Part 2 though is there is no reason to trade much on the plus side of $3 before 2019 so risk exceeds reward still. Watch for the pivot point of risk vs reward, but insider confidence says to me get it hot at $1.75 but don't be a pig
It is hard to abstract clarity but I like $7 million so 50 - 4 - 7 would be close to $39 million free and clear if August comes in big time.
I am reluctant to look a gift horse in the mouth if there is a $27 to $50 million gift horse
Dilution ongoing under variable rate financing was a mushroom cloud. To only have 30 or so fold financing this time would be a big improvement as all the cash would mean so much. Everybody should be on their knees praying gross of $46 million raised in a heartbeat. IF their was ever a good dilution under Simpson, that would be it, amazing the lack of understanding.
The company when near bust last year carried a market cap of around $75 million in July and August. A market cap of $75 million on 30 million shares would be $2.50 except the company would have between $30 million to $40 million cash and could be announcing between good and great news on phase 3 within 6 to 9 months.
I am not impressed. Unless there was a buyout, what alternative is there?